09/11/2014 - 1:21pm

The Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as a chronic weight-management option. 

09/10/2014 - 10:38am

America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention.

09/10/2014 - 9:47am

RAP Protein Gummies brought a protein gummy product to market Wednesday. 

09/09/2014 - 11:54am

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.

09/05/2014 - 2:11pm

Merck on Thursday announced that the Food and Drug Administration granted accelerated approval to Keytruda (pembrolizumab) for the treatment of patients with advanced melanoma.

09/05/2014 - 10:29am

Mylan on Friday announced that it has launched a generic version of Hoffmann-La Roche's Boniva injection.

09/05/2014 - 9:32am

Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.

09/04/2014 - 10:33am

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 

09/03/2014 - 4:25pm

Procter & Gamble on Wednesday announced the introduction of Vicks QlearQuil, a family of over-the-counter medications for the occasional allergy sufferer.